BioLight Life Sciences Ltd. (TLV:BOLT)
Israel · Delayed Price · Currency is ILS · Price in ILA 328.50
+6.40 (1.99%)
At close: Mar 13, 2026
BioLight Life Sciences Market Cap
BioLight Life Sciences has a market cap or net worth of 29.72 million as of March 13, 2026. Its market cap has increased by 33.27% in one year.
Market Cap
29.72M
Enterprise Value
8.42M
Revenue
21.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
328.50
Market Cap Chart
Since January 11, 2006, BioLight Life Sciences's market cap has decreased from 47.74M to 29.72M, a decrease of -37.75%. That is a compound annual growth rate of -2.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 29.72M | -6.62% |
| Dec 31, 2025 | 31.83M | 25.69% |
| Dec 31, 2024 | 25.32M | 4.99% |
| Dec 31, 2023 | 24.12M | -19.99% |
| Dec 29, 2022 | 30.15M | -42.70% |
| Dec 30, 2021 | 52.62M | 53.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bonus BioGroup | 498.70M |
| Geffen Residence & Renewal | 263.65M |
| Matricelf | 142.71M |
| Clal Biotechnology Industries | 44.86M |
| BioLineRx | 39.16M |
| Evogene | 20.51M |
| XTL Biopharmaceuticals | 19.87M |
| Purple Biotech | 18.58M |